Back
Carisma Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
CARM
Carisma Therapeutics, Inc.
Last Price:
$0.03
Seasonality Move:
22.98%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and CARM is experiencing selling pressure, which indicates risk of future bearish movement.
Carisma Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.03 | Buy |
| 20-day SMA: | 0.04 | Sell |
| 50-day SMA: | 0.04 | Sell |
| 200-day SMA: | 0.16 | Sell |
| 8-day EMA: | 0.03 | Buy |
| 20-day EMA: | 0.03 | Buy |
| 50-day EMA: | 0.02 | Buy |
| 200-day EMA: | 0.01 | Buy |
Carisma Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 42.87 | Sell |
| Chaikin Money Flow: | -11527 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.04 - 0.04) | Sell |
| Bollinger Bands (100): | (0.03 - 0.05) | Sell |
Carisma Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Carisma Therapeutics, Inc. Stock
Is Carisma Therapeutics, Inc. Stock a Buy?
-
Carisma Therapeutics, Inc. share price is 0.03 while CARM 8-day simple moving average is 0.03, which is a Buy signal.
-
The stock price of CARM is 0.03 while Carisma Therapeutics, Inc. 20-day SMA is 0.04, which makes it a Sell.
-
Carisma Therapeutics, Inc. 50-day simple moving average is 0.04 while CARM share price is 0.03, making it a Sell technically.
-
CARM stock price is 0.03 and Carisma Therapeutics, Inc. 200-day simple moving average is 0.16, creating a Sell signal.
CARM Technical Analysis vs Fundamental Analysis
Sell
20
Carisma Therapeutics, Inc. (CARM)
is a Sell
Is Carisma Therapeutics, Inc. a Buy or a Sell?
-
Carisma Therapeutics, Inc. stock is rated a SellThe current Carisma Therapeutics, Inc. [CARM] share price is $0.03. The Score for CARM is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Carisma Therapeutics, Inc. Stock Info
Market Cap:
1.4M
Price in USD:
0.03
Share Volume:
183.2K
Carisma Therapeutics, Inc. 52-Week Range
52-Week High:
1.27
52-Week Low:
0.03
Sell
20
Carisma Therapeutics, Inc. (CARM)
is a Sell
Carisma Therapeutics, Inc. Share Price Forecast
-
What is the Carisma Therapeutics, Inc. stock price today?The Carisma Therapeutics, Inc. stock price is 0.03 USD today.
-
Will CARM stock go up or go down?Carisma Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Carisma Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Carisma Therapeutics, Inc. is overvalued.
Is Carisma Therapeutics, Inc. Stock a Buy?
-
Carisma Therapeutics, Inc. share price is 0.03 while CARM 8-day exponential moving average is 0.03, which is a Buy signal.
-
The stock price of CARM is 0.03 while Carisma Therapeutics, Inc. 20-day EMA is 0.03, which makes it a Buy.
-
Carisma Therapeutics, Inc. 50-day exponential moving average is 0.02 while CARM share price is 0.03, making it a Buy technically.
-
CARM stock price is 0.03 and Carisma Therapeutics, Inc. 200-day simple moving average is 0.01, creating a Buy signal.
Fundamental Analysis of Carisma Therapeutics, Inc.
Is Carisma Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Carisma Therapeutics, Inc.
Should I short Carisma Therapeutics, Inc. stock?
-
CARM Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Carisma Therapeutics, Inc. is a Buy
-
Carisma Therapeutics, Inc. Relative Strength Index (RSI) is 42.87, which suggest Carisma Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Carisma Therapeutics, Inc. is (0.04 - 0.04), which suggest Carisma Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Carisma Therapeutics, Inc. is (0.03 - 0.05), which suggest Carisma Therapeutics, Inc. is a Sell
* Carisma Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.